On the other hand, in three renal carcinomas (chromophobe (KICH), clear cell carcinoma (KIRC), and papillary cell carcinoma (KIRP)), hepatocellular carcinoma (LIHC), and prostate adenocarcinoma (PRAD), NEAT1 expression was significantly increased. This evidence concerns the gene NEAT1 and prostate adenocarcinoma.